Menu

Global Klinefelter Syndrome Therapeutics Market Size, Share, Industry Statistics Report, By Age Group (Below 16, 17 – 30 Years, 31 – 50 Years, 51 Years & Above); By Type of Treatment (Testosterone Replacement Therapy, Fertility Treatment (Surgeries, Hormone Treatments, Others)); By Form (Oral, Patches (Transdermal, Mouth), Gels, Injections, Pellets); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France and Other) (Middle East and Africa and RoW) - Global Industry Insights, Trends and Forecast, 2017-2025

Report Format : PDF
Published Date : Sep-2018
Pages : 180
Report ID : VSR00544

Global Klinefelter Syndrome Therapeutics Market showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx billion over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 5.21% during the forecast period that is 2017-2025. Klinefelter Syndrome Therapeutics Market Size is predicted to grow over notable CAGR over the forecast period, owing to increasing infertility cases, hormone disorders, especially among the male population. Klinefelter syndrome is a common genetic chromosomal condition, in which a male is usually born with an additional copy of X chromosome. This health disorder only affects males, and is highly undiagnosed. Around one in every 650 males have the chance to get affected.

Global Klinefelter Syndrome Therapeutics Market Size, Share Analysis By Region 2017

Klinefelter Syndromne Therapeutics Market Size

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global klinefelter syndrome therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global klinefelter syndrome therapeutics market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.   

Market Dynamics

Klinefelter syndrome is a major chromosomal condition which affects cognitive and physical development of males. The symptoms vary among all individuals who are affected. Fertility disorder cases among the male population is increasing significantly from the past few years, which will primarily drive the market. The symptoms will be developed among males among all age groups. This disease is majorly observed among new-born males. According to stats by the National Institute of Health (NIH), one person in 500 to 1,000 new born males are affected by Klinefelter syndrome.

According to the researchers at the NIH, the Klinefelter syndrome is highly underdiagnosed, due to its unidentifiable symptoms and signs among males. The signs of this condition differ and overlap with symptoms caused by other health disorders. Due to this, various organizations functioning in the Healthcare sector such as the NIH and FDA are increasing their awareness campaigns regarding this health disorder, by stressing the parents to conduct all kinds of health check-ups to identify this disease for their new-born baby. This disease, if detected at an early stage, can be prevented from development. Moreover, the awareness among the population is also increasing significantly from the past few years, which will act as another significant factor favoring the growth of this market.

Klinefelter syndrome therapeutics market size might be restrained by the lack of awareness among the population in the developing nations of Asia Pacific, Europe, Africa and Middle East regions. This market can further be restrained by the shortage of treatment facilities in these economies.

Segment Analysis

By Type of Treatment Analysis: By type of treatment, the Klinefelter therapeutics market has been segmented into testosterone replacement therapy, fertility treatment, and others. Fertility treatment segment is further segmented into surgeries, hormone treatments, etc. Testosterone replacement is the most common treatment method preferred by majority of the population of adult age groups (17 years to 50 years).

By Form Insights: Based on form, the global Klinefelter therapeutics market share has been segmented into oral, patches, gels, injections, and pellets. Patches are further segmented into transdermal and mouth (buccal). Injection-based Klinefelter therapeutics market is predicted to have the prime market share, owing to its high preference for males among the new born to 14 years age group.

Patches-based Klinefelter therapeutics market is expected to grow at a prime CAGR throughout the forecast period. This is majorly due to increasing product preference among people of age groups 17 – 30 years, 31 – 50 years, and 51 & above.

Region Analysis

The global klinefelter syndrome therapeutics market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America Klinefelter syndrome therapeutics market is predicted to dominate the global market over the entire forecast period. This is majorly due to high presence of testosterone drug manufacturers, coupled with increased awareness among the population of this region. Moreover, huge presence of treatment centers for this disorder will further enhance the market share over the forecast period.

Asia Pacific market is predicted to grow at a higher CAGR, owing to the increase awareness of people regarding this disorder. Additionally, this market will be driven by the increasing testosterone manufacturing in the developing countries of this region such as India and China. Middle East and Africa held the measurable growth in the global market in 2018 and will expand at the significant CAGR during the forecast years.    

Global Klinefelter Syndrome Therapeutics Market Study Objective

1. To forecast the market size of klinefelter syndrome therapeutics market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of klinefelter syndrome therapeutics market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of klinefelter syndrome therapeutics market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of klinefelter syndrome therapeutics market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the klinefelter syndrome therapeutics market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Some of the key players in the global klinefelter syndrome therapeutics market include Lupin Pharmaceuticals, Allergan plc, AbbVie, Inc., Endo Pharmaceuticals, Inc., Kyowa Kirin International plc, Eli Lilly and Company, Pfizer, Inc., and Mylan N.V. and among several others.

Major global pharmaceutical companies are working towards the development of various testosterone drugs, which will further help to enhance their respective market share. For instance, in February 2016, Lupin Pharmaceuticals, Inc. launched a testosterone topical solution in the U.S. for males, who are suffering from hormone deficiencies.

Moreover, several global pharmaceutical companies got their approval for testosterone drugs the U.S. FDA, and other healthcare organizations, which will help them to develop more variants for this drug. Currently, majority of these players are into the production and distribution of testosterone drug in the form of patches, injections, oral form, etc.

Global Klinefelter Syndrome Therapeutics Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Enquiry for Table of Content

Global Klinefelter Syndrome Therapeutics Market Size, Share, Industry Statistics Report, By Age Group (Below 16, 17 – 30 Years, 31 – 50 Years, 51 Years & Above); By Type of Treatment (Testosterone Replacement Therapy, Fertility Treatment (Surgeries, Hormone Treatments, Others)); By Form (Oral, Patches (Transdermal, Mouth), Gels, Injections, Pellets); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France and Other) (Middle East and Africa and RoW) - Global Industry Insights, Trends and Forecast, 2017-2025

Enquiry for Methodology

Global Klinefelter Syndrome Therapeutics Market Size, Share, Industry Statistics Report, By Age Group (Below 16, 17 – 30 Years, 31 – 50 Years, 51 Years & Above); By Type of Treatment (Testosterone Replacement Therapy, Fertility Treatment (Surgeries, Hormone Treatments, Others)); By Form (Oral, Patches (Transdermal, Mouth), Gels, Injections, Pellets); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France and Other) (Middle East and Africa and RoW) - Global Industry Insights, Trends and Forecast, 2017-2025

Single User: $4,999
Multi User: $6,999
Enterprice Licence: $8,999

Get 15% Discount

Why Choose Veracious Statistics Research ?

Save Your Time

Cost-Effective Services

Wide Range of Reports

World Class Market Research

100% Customer Satisfaction

24/7 Customer care Support

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

Contact us

Sales Shaulova

Global Operations Manager +1-937-947-0908 Mon - Fri - 24/7/

Let's Talk Online